Rupert Lanzenberger: Clinical Trials

5 trials sponsored by Rupert Lanzenberger, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 unknown, 1 completed, 1 recruiting. 4 Not applicable, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable4Unknown 3, Recruiting 1
Phase 11Completed 1

Follow Rupert Lanzenberger: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Impact of Stress on Brain Energy Metabolism
Montreal Imaging Stress Test - Stress
Not applicableRecruitingRupert Lanzenberger682024-03-012025-12-23
Investigation of Intranasal Ketamine Related Changes in Attentional Brain Networks With Functional and Structural MRI
56mg esketamine (2x Spravato® 28 mg nasal spray), 0.9% saline solution nasal spray - Ketamine Treatment
Phase 1CompletedRupert Lanzenberger332022-06-012024-04-15
TBS in Major Depression
theta-burst stimulation (TBS) using a MagPro X1000 - Treatment Resistant Depression
Not applicableUnknownRupert Lanzenberger802017-08-012019-03-13
Simultaneous PET/MR Imaging of Human Brain Plasticity
Tetris - Neuronal Plasticity
Not applicableUnknownRupert Lanzenberger402017-05-012019-09-23
Effects of TBS on 5-HT1A Receptor Binding
theta-burst stimulation using a MagPro X1000, sham stimulation using a MagPro X1000 - Treatment Resistant Depression
Not applicableUnknownRupert Lanzenberger802016-12-012018-08-16

Conditions studied

Depressive Disorder, Treatment-Resistant (2)

Interventions

Transcranial Magnetic Stimulation (2)  ·  Esketamine (1)  ·  Nasal Sprays (1)

Countries

Austria (5)

Top investigators

Andreas Hahn, Assoc.Prof. (1)  ·  Siegfried Kasper, MD (1)

Results publications

PMID 32314956, PMID 41693798